Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Early clinical studies suggest that retatrutide may improve cardiometabolic profiles by reducing blood pressure and improving lipid levels, further underscoring its promise for addressing both metabolic and cardiovascular risk factors in individuals with obesity and diabetes.
Neither compound holds MHRA or EMA marketing authorisation
If you have a 50/50 mix in the same vial, you would withdraw a TOTAL of 40 MCG into the syringe, since there is an equal amount of each peptide in the mix you would be getting 20 MCG of each product
Our experienced medical team is committed to delivering personalized care and honest, expert guidance throughout your treatment, so you know exactly what BPC-157 can and cannot do for your goals
US$ 25.89
US$ 27.15
US$ 20.38
US$ 22.26
US$ 21.07
US$ 29.46
US$ 25.60
US$ 23.17
US$ 25.07
